| Name | Title | Contact Details |
|---|
Surgipath Medical Industries is a worldwide leader in the development, manufacture and supply of quality product solutions for the Anatomical Pathology Laboratory. Since we were founded, our fundamental business strategies ensure our customer's
To improve the lives of those impacted by disease and disability. To provide accessible, accurate, and reliable analysis in a way that facilitates and adapts to our clients` needs to progress their clinical trials at the fastest possible pace. While our technology makes us unique, it is our people who make us special. Our teams utilize creativity, flexibility and expertise to design personalized solutions to meet our customers` goals and objectives. But what truly sets us apart is the internal motivation of our employees and the pride they take in helping customers affect the lives of those in need.
MediBeacon was formed in 2012 specifically to acquire the optical diagnostic program from Mallinckrodt, the Pharmaceuticals business of Covidien. MediBeacon mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. Several product concepts in these arenas are contained in the MediBeacon Intellectual Property (IP) portfolio.
G&J Medical Supply is a Asheville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MEDX Ventures Group, founded in 2010, is an investment and management company with offices in Israel, USA and Europe. The company believes in active management (as opposed to passive investment), and is focusing on medical ventures and technologies in Israel while utilizing the Company`s unique X Model to include its core Development, Regulatory, Commercial and Finance team that manages a portfolio of ventures. MEDX Ventures Group capitalizes on its global presence while utilizing Israel`s unique research, development and operations capabilities in the field; As such the company focuses on smart investment, reduced risk, short time to market and efficient return on investment. MEDX Ventures Group is led by highly experienced medical device management and investment team from different aspects of the business to ensure the Company`s X Model is fully implemented and executed in each of its activities and ventures. In addition, the company continuously seeks alliances with global industry leaders, beginning in project development stage, to ensure medical innovations become the life changing reality for patients and providers, while becoming a profitable business to all stakeholders and generating attractive return for investors.